Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes

Hepatology

Volumn 26, Issue 5, 1997, Pages 1138-1142

  Jones, David E J ^a,b   Metcalf, Jane V ^a   Collier, Jane D ^a   Bassendine, Margaret F ^a   James, Oliver F W ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CAUSE OF DEATH; CHRONIC LIVER DISEASE; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE;

EID: 0030716327     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510260508     Document Type: Article

References (30)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996;335:1570-1581.
2. Bassendine MF. Aetiological factors in hepatocellular carcinoma. Ballieres Clin Gastroenterol 1987;1:1-16.
3. De Bac C, Stroffolini T, Gaeta GB, Taliani G, Giusti G. Pathogenic factors in cirrhosis with and without hepatocellular carcinoma. HEPATOLOGY 1994;201225-1230.
4. Kaczynski J, Hansson G, Wallerstedt S. Incidence of primary liver cancer and aetiological aspects: a study of a defined population from a low-endemicity area. Br J Cancer 1996;73:1225-1230.
5. Villa E, Baldini GM, Pasquinelli C, Melegari M, Cariani E, Di Chirico G, Manenti M. Risk factors for hepatocellular carcinoma in Italy. Cancer 1988;62:611-665.
6. Metcalf J, James OFW. The geoepidemiology of pimary biliary cirrhosis. Semin Liver Dis 1997;17:13-22.
7. Turissini SB, Kaplan MM. Hepatocellular carcinoma in primary biliary cirrhosis. Am J Gastroenterol 1997;92:676-678.
8. Melia WM, Johnson PJ, Neuberger J, Zaman S, Portmann BC, Williams R. Hepatocellular carcinoma in primary biliary cirrhosis: detection by α-fetoprotein estimation. Gastroenterology 1984;87:660-663.
9. Loof L, Adami H-O, Sparen P, Danielsson A, Eriksson LS, Hultcrantz R, Lindgren S, et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. HEPATOLOGY 1994;20:101-104.
10. Farinati F, Floreani A, De Maria N, Fagiuoli S, Naccarato R, Chiaramonte M. Hepatocellular carcinoma in primary biliary cirrhosis. J Hepatol 1994;21:315-316.
11. Wiesner RH, Porayko MK, Dickson ER, Gores GJ, LaRusso NF, Hay JE, Wahlstrom HE, et al. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. HEPATOLOGY 1992;16:1290-1299.
12. Klion FM, Fabry TL, Palmer M, Schaffner F. Prediction of survival of patients with primary biliary cirrhosis. Gastroenterology 1992;102:310-313.
13. Scheuer PJ. Primary biliary cirrhosis. Proc R Soc Med 1967;60:1257-1260.
14. Ludwig J, Dickson ER, McDonald GSA. Staging of chronic non-supperative destructive cholangitis (syndrome of primary biliary cirrhosis). Virch Arch A Pathol Anat Histopathol 1978;379:103-122.
15. Curley SA, Izzo F, Gallipoli A, de Bellis M, Cremona F, Parisi V. Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg 1995;222:375-383.
16. Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985;I:1357-1360.
17. Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocelluar carcinoma. Ann Intern Med 1988;108:390-401.
18. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. HEPATOLOGY 1993;18:47-53.
19. Tarao K, Shimuzu A, Harada M, Kuni Y, Ito Y, Tamai S, et al. Difference in the in vitro uptake of bromodeoxyuridine between liver cirrhosis with and without hepatocellular carcinoma. Cancer 1989;64:104-109.
20. Tarao K, Ohkawa S, Shimuzu A, Harada M, Nakamura Y, Ito Y, Tamai S, et al. The male preponderence in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men. Cancer 1993;72:369-374.
21. Rizvi TA, Mathur M, Nayak NC. Enhancement of aflatoxin B1-induced hepatocarcinogenesis in rats by partial hepatectomy. Virchow Archiv B Cell Pathol 1989;56:345-350.
22. Nagasue N, Yukaya H, Chang Y-C, Ogawa Y, Kohno H, Ito A. Active uptake by androgen receptors of hepatocellular carcinoma in humans. Cancer 1986;57:2162-2167.
23. Collier JD, Curless R, Bassendine MF, James OFW. Clinical features of hepatocellular carcinoma in Britain in relation to age. Age Ageing 1994; 23:22-27.
24. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels: Analysis of 606 patients. Cancer 1989;64:1700-1707.
25. Poupon RE, Poupon R, Balkou B. Ursodiol for the long-term treatment of primary bilairy cirrhosis. N Engl J Med 1994;330:1342-1347.
26. Lindor KD, Dickson ER, Baldus WP, Jorgenson RA, Ludwig J, Murtaugh PA, Harrison JM, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284-1290.
27. Jones DEJ, James OFW, Bassendine MF. Ursodeoxycholic acid therapy in primary biliary cirrhosis. HEPATOLOGY 1995;21:1469-1473.
28. Kew MC, Popper H. Relationship betweeen hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984;4:136-146.
29. Markus BH, Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GBG, Wiesner RH, et al. Efficacy of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989;320:1709-1713.
30. Neuberger J, Attman DG, Polson R, Buckels J, Rolles K, Elias E, Calne R, et al. Prognosis after liver transplantation for primary biliary cirrhosis. Transplantation 1989;48:444-447.